Meaghen E. Sharik
WinnMed(US)Mayo Clinic in Arizona(US)Mayo Clinic Hospital(US)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Peptidase Inhibition and Analysis, Histone Deacetylase Inhibitors Research, Signaling Pathways in Disease
Most-Cited Works
- → Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression(2018)214 cited
- → IAP antagonists induce anti-tumor immunity in multiple myeloma(2016)171 cited
- → Tumor Burden Limits Bispecific Antibody Efficacy through T-cell Exhaustion Averted by Concurrent Cytotoxic Therapy(2021)98 cited
- → Inhibitors of the protein disulfide isomerase family for the treatment of multiple myeloma(2018)56 cited
- → Identification of PIKfyve kinase as a target in multiple myeloma(2019)39 cited
- → Monosomic Loss of MIR15A/MIR16-1 Is a Driver of Multiple Myeloma Proliferation and Disease Progression(2020)39 cited
- → Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma(2023)34 cited
- → The genomic landscape of Vk*MYC myeloma highlights shared pathways of transformation between mice and humans(2024)12 cited
- → Transplantation of autologous bone marrow pre-loaded ex vivo with oncolytic myxoma virus is efficacious against drug-resistant Vk*MYC mouse myeloma(2022)8 cited
- → An immunostimulatory CELMoD combination overcomes resistance to T-cell engagers caused by a high multiple myeloma burden(2025)5 cited